A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803
- Citation:
- Oncologist vol 22 (1) 107-114
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- 6
- Parents:
- 752
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10 CA031946, U10 CA033601, U10 CA180821, P30 CA023108, U10 CA180882, U24 CA196171, T32 DK007754
- Corr. Author:
- Authors:
- Donna Niedzwiecki Rian M. Hasson Heinz‐Josef Lenz Cynthia Ye Mark Redston Shuji Ogino Charles S. Fuchs Carolyn C. Compton Robert J. Mayer Richard M. Goldberg Thomas A. Colacchio Leonard B. Saltz Robert S. Warren Monica M. Bertagnolli
- Networks:
- CA011, LAPS-CT018, LAPS-MA036, LAPS-NH012, LAPS-NY016, LAPS-OH007
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-89803, CALGB-9581
- Phases:
- 3
- Keywords:
- Colon cancer, Biomarkers, Adjuvant therapy, Thymidylate synthase, Microsatellite instability, Mismatch repair deficiency